Literature DB >> 9199206

CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.

M Schroeder1, M J Mass.   

Abstract

Alterations of the methylation patterns of DNA are common in cancer cells and could conceivably comprise a subset of causal events in the carcinogenesis process. Although it has previously been shown that methylation of CpG islands in the 5'-control regions of tumor suppressor genes such as p16, Von Hippel-Lindau (VHL) syndrome gene, and the retinoblastoma (RB) gene can suppress expression and function of these gene products, the elements that control the expression of the p53 gene have not been examined in detail. In this study we examined the effect of CpG methylation in a region of the p53 promoter containing major transcription start sites. A region of the p53 promoter (from -199 to +142) containing 15 CpG dinucleotides was placed in a pCAT reporter plasmid and reporter activity was assessed in host CV-1 cells. We show for the first time that transcriptional activation of the p53 tumor suppressor gene, as assessed by a reporter plasmid construct, can be down-regulated by cytosine methylation in the basal promoter region. We believe these data suggest a role for methylation of CpG sequences in the regulation of transcription of p53. This implies that the tumor suppressor gene p53 could, therefore, contribute to carcinogenesis by inactivation via methylation of a key element in cell cycle control.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199206     DOI: 10.1006/bbrc.1997.6796

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation.

Authors:  Nicola Wanner; Julia Vornweg; Alexander Combes; Sean Wilson; Julia Plappert; Gesa Rafflenbeul; Victor G Puelles; Raza-Ur Rahman; Timur Liwinski; Saskia Lindner; Florian Grahammer; Oliver Kretz; Mary E Wlodek; Tania Romano; Karen M Moritz; Melanie Boerries; Hauke Busch; Stefan Bonn; Melissa H Little; Wibke Bechtel-Walz; Tobias B Huber
Journal:  J Am Soc Nephrol       Date:  2018-12-05       Impact factor: 10.121

Review 2.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

3.  Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.

Authors:  Jian Huang; Keqiang Chen; Jiaqiang Huang; Wanghua Gong; Nancy M Dunlop; O M Zack Howard; Xiuwu Bian; Yuqi Gao; Ji Ming Wang
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

4.  TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status.

Authors:  Dorota Jesionek-Kupnicka; Malgorzata Szybka; Beata Malachowska; Wojciech Fendler; Piotr Potemski; Sylwester Piaskowski; Dariusz Jaskolski; Wielislaw Papierz; Wieslaw Skowronski; Waldemar Och; Radzislaw Kordek; Izabela Zawlik
Journal:  DNA Cell Biol       Date:  2014-02-07       Impact factor: 3.311

5.  Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene.

Authors:  S Contente; K Kenyon; P Sriraman; S Subramanyan; R M Friedman
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 6.  G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma.

Authors:  Mingyong Liu; Jianhua Zhao; Keqiang Chen; Xiuwu Bian; Chunyan Wang; Ying Shi; Ji Ming Wang
Journal:  Int Immunopharmacol       Date:  2012-08-02       Impact factor: 4.932

7.  Polymorphisms in promoter sequences of MDM2, p53, and p16 genes in normal Japanese individuals.

Authors:  Yasuhito Ohsaka; Hoyoku Nishino
Journal:  Genet Mol Biol       Date:  2010-12-01       Impact factor: 1.771

8.  Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.

Authors:  Yan Huang; Qiang Du; Weibao Wu; Feifei She; Yanling Chen
Journal:  Mol Med Rep       Date:  2016-07-19       Impact factor: 2.952

Review 9.  Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma.

Authors:  Ana B Herrero; Elizabeta A Rojas; Irena Misiewicz-Krzeminska; Patryk Krzeminski; Norma C Gutiérrez
Journal:  Int J Mol Sci       Date:  2016-11-30       Impact factor: 5.923

10.  EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing's Sarcoma.

Authors:  Mohammad Motarab Hossain; Swapan Kumar Ray
Journal:  J Cancer Ther       Date:  2014-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.